Pain outcomes in patients with advanced breast cancer and bone metastasesCharles S. Cleeland, Karen Chung, Stefania Salvagni et al.|Cancer|2012Cited by 155
An open‐label, phase 2 trial of denosumab in the treatment of relapsed or plateau‐phase multiple myelomaRavi Vij, Susie Jun, Robert Vescio et al.|American Journal of Hematology|2009Cited by 97
Pain and health-related quality of life in patients with advanced solid tumours and bone metastases: integrated results from three randomized, double-blind studies of denosumab and zoledronic acidRoger von Moos, Karen Chung, Jean-Jacques Body et al.|Supportive Care in Cancer|2013Cited by 94
Pain and analgesic use associated with skeletal-related events in patients with advanced cancer and bone metastasesRoger von Moos, Yi Qian, Jean-Jacques Body et al.|Supportive Care in Cancer|2015Cited by 79
Effects of denosumab on pain and analgesic use in giant cell tumor of bone: Interim results from a phase II studyJavier Martín‐Broto, C. Atchison, Charles S. Cleeland et al.|Acta Oncologica|2014Cited by 69